Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GNRHR | P30968 | 20/20 | 0.82 |
| ▸ | MEN1 | O00255 | 1/20 | 0.66 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6545383 | 0.90 | GNRHR (1.00) | GNRHRMEN1KMT2A | |
| Hydrochloric Acid SCHEMBL7827346 | 0.90 | GNRHR (0.99) | GNRHRMEN1KMT2A | |
| SCHEMBL5074740 | 0.89 | GNRHR (0.73) | GNRHRMEN1KMT2A | |
| SCHEMBL5076165 | 0.89 | GNRHR (0.66) | GNRHRMEN1KMT2A | |
| SCHEMBL5076166 | 0.88 | GNRHR (0.69) | GNRHRMEN1KMT2A | |
| SCHEMBL5076715 | 0.88 | GNRHR (0.69) | GNRHRMEN1KMT2A | |
| SCHEMBL7827375 | 0.88 | GNRHR (0.85) | GNRHRMEN1KMT2A | |
| SCHEMBL7829165 | 0.85 | GNRHR (0.84) | GNRHRMEN1KMT2A | |
| SCHEMBL8152088 | 0.83 | GNRHR (0.84) | GNRHRMEN1KMT2A | |
| SCHEMBL7827279 | 0.83 | GNRHR (0.85) | GNRHRMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080207524-A1 | MEDICINAL PREPARATIONS FOR TREATING SEX HORMONE-DEPENDENT DISEASES | TAKEDA PHARMACEUTICAL COMPANY LIMITED | 2008-08-28 | — | — | US | disclosed |
| US-20030176360-A1 | Medicinal preparations for treating sex hormone-dependent diseases | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2003-09-18 | — | — | US | disclosed |
| EP-1297850-A1 | MEDICINAL PREPARATIONS FOR TREATING SEX HORMONE-DEPENDENT DISEASES | Takeda Chemical Industries, Ltd. (JP) | 2003-04-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080207524-A1 | MEDICINAL PREPARATIONS FOR TREATING SEX HORMONE-DEPENDENT DISEASES | SHBG, GNRHR, NR5A1 | GNRHR 2/4885MEN1 161/4885KMT2A 758/4885 |
| US-20030176360-A1 | Medicinal preparations for treating sex hormone-dependent diseases | SHBG, GNRHR, NR5A1 | GNRHR 2/4885MEN1 161/4885KMT2A 758/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.